Comparison of 1 mg and 2 mg overnight dexamethasone suppression tests for the screening of Cushing's syndrome in obese patients.

@article{ahin2009ComparisonO1,
  title={Comparison of 1 mg and 2 mg overnight dexamethasone suppression tests for the screening of Cushing's syndrome in obese patients.},
  author={Mustafa Şahin and Levent Kebapcilar and Abdullah Taşlipinar and Omer Azal and Taner Ozgurtas and Ahmet Çorakçi and Emin Ozgur Akgul and Mine Yavuz Taslipinar and Mahmut Yazici and Mustafa Kutlu},
  journal={Internal medicine},
  year={2009},
  volume={48 1},
  pages={33-9}
}
OBJECTIVE Obesity is currently a major public health problem and one of the potential underlying causes of obesity in a minority of patients is Cushing's syndrome (CS). Traditionally, the gold standard screening test for CS is 1 mg dexamethasone overnight suppression test. However, it is known that obese subjects have high false positive results with this test. DESIGN We have therefore compared the 1 mg and 2 mg overnight dexamethasone suppression tests in obese subjects. Patients whose serum… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Difficulties in excluding Cushing syndrome in obese subjects

HA Tran, N. Petrovsky
The Endocrinologist • 2006
View 1 Excerpt

Diagnosis and complications of Cushing's syndrome: a consensus statement.

The Journal of clinical endocrinology and metabolism • 2003
View 3 Excerpts

Similar Papers

Loading similar papers…